Company Overview

Grapefruit USA, Inc. (OTC Pink: GPFT) is a U.S.-based holding and operating company historically focused on the legal cannabis industry, including cannabis cultivation, manufacturing, distribution, and consumer wellness products. Public filings and company disclosures indicate that the company has operated primarily through California-based cannabis assets and has marketed cannabinoid-related consumer products under proprietary brands. The company has also explored technology-oriented initiatives tied to intellectual property, licensing, and digital platforms connected to cannabis retail and consumer engagement.

The company’s primary revenue drivers have historically included cannabis-derived products, white-label manufacturing, extraction, and branded consumer offerings. Grapefruit USA became known for promoting its “Hourglass” time-release THC delivery cream technology and related topical wellness products. Its customer base has primarily consisted of cannabis consumers and licensed dispensary channels within regulated U.S. markets, particularly California. Based on available public sources, the company evolved from broader wellness and cannabis-related ventures into a more focused intellectual property and branded-product strategy, although certain operational details and current commercial scale remain limited or inconsistently disclosed across public filings and OTC market materials.

Business Operations

Grapefruit USA has historically operated through cannabis-related subsidiaries and affiliated operating entities involved in cultivation, extraction, manufacturing, and product commercialization. Public disclosures reference operations associated with California cannabis licensing frameworks, including manufacturing and distribution activities tied to THC and CBD consumer products. The company’s business model has included direct product sales, licensing opportunities, and commercialization of proprietary formulations and delivery systems.

The company’s operations appear to have been concentrated primarily in the United States, with California serving as the core operational market. Publicly available information references intellectual property assets connected to the “Hourglass” topical delivery technology, along with cannabis processing and product-development capabilities. Certain references to strategic partnerships and distribution arrangements have appeared in company announcements; however, the scope, duration, and commercial impact of some partnerships cannot be independently verified through consistent regulatory disclosures. Data inconclusive based on available public sources regarding the current operational scale of several previously announced business initiatives.

Strategic Position & Investments

Grapefruit USA’s strategic direction has centered on developing differentiated cannabis wellness products and leveraging proprietary cannabinoid delivery technologies within regulated cannabis markets. Company disclosures have emphasized intellectual property development, product branding, and expansion opportunities tied to topical THC applications and consumer wellness trends. The company has also publicly discussed efforts related to digital commerce and broader technology integration within cannabis retail ecosystems.

Historically disclosed investments and initiatives have included the development and commercialization of the Hourglass product platform and related manufacturing capabilities. Public announcements have also referenced acquisition activity and subsidiary development intended to strengthen vertical integration within the cannabis supply chain. However, several announced strategic initiatives appear to have had limited follow-through in subsequent regulatory reporting, and independently verified financial or operational outcomes for some projects remain unclear. Data inconclusive based on available public sources regarding the long-term commercial adoption of certain proprietary technologies and investment initiatives.

Geographic Footprint

Grapefruit USA’s operational footprint has primarily been concentrated in the United States, particularly California, where cannabis licensing, manufacturing, and distribution activities have historically been conducted. The company’s headquarters and principal business activities have been associated with Southern California according to OTC disclosures and corporate filings. Its market presence has largely targeted state-regulated cannabis consumers and dispensary networks rather than broad international expansion.

While company communications have occasionally referenced broader expansion ambitions, publicly verifiable evidence of substantial operational infrastructure outside the United States remains limited. No major independently verified international operating divisions or large-scale overseas investments were consistently identified in available public filings. Data inconclusive based on available public sources regarding the extent of current active operations outside California and the broader U.S. market.

Leadership & Governance

Grapefruit USA has been led by executives with backgrounds in cannabis operations, corporate development, and entrepreneurial ventures. Public filings and OTC disclosures indicate that leadership strategy has focused on product differentiation, intellectual property development, and positioning the company within emerging regulated cannabis and wellness markets. Governance information available through OTC Markets and corporate disclosures suggests a relatively lean executive structure typical of smaller public cannabis-sector issuers.

Key executives publicly associated with the company include:

• Bradley J. Yourist – Chief Executive Officer
• Bradley J. Yourist – Director
• Steve Tobin – Former executive and operational leadership roles associated with cannabis operations

Based on publicly available disclosures, leadership messaging has consistently emphasized innovation in cannabinoid delivery systems, consumer wellness branding, and long-term participation in regulated cannabis markets. Certain executive and governance details have varied across reporting periods, and some historical leadership information could not be consistently verified across all public records.